Scholars Central

Conference abstractPublished 18 Oct 2018

Trastuzumab treatment-related cardiotoxicity: A storm in a teacup

Authors: Bruno H R De Paula, Maria Eduarda Ferro Costa, Jose Bines

National Cancer Institute, Brazil

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Cardiotoxicity (CT) is the most concerning side effect of trastuzumab. It remains unclear whether the current arbitrary recommendations provide an adequate balance between preventing heart damage and curtailing a curative treatment. Objective: The main objective of this study was to determine the incidence rate and consequences of CT during (neo) adjuvant trastuzumab treatment in a realworld scenario. Methods: Retrospective analysis of cardiac monitoring was done during trastuzumab-based neo- and adjuvant breast cancer treatment at a large public medical hospital. Results: Four hundred and nine (409) breast cancer patients were treated with (neo) adjuvant-based trastuzumab between 2011 and 2014. The median age was 52 years and the body mass index (BMI) 27.54 kg/m2. The mean number of echo/ patient was five. (Figure 1) Although none of these patients were symptomatic, all of them had their treatment delayed due to the echo findings. Twenty eight patients (75.6%) recovered their cardiac function and 9 (24.4%) had trastuzumab suspended. There were 14 deaths (6.3%) in the studied sample, being 1 (0.2%) attributed to late CE (4 years after treatment). (Figure 2) Conclusion: Frequent monitoring of cardiac function during (neo)-adjuvant treatment was associated with 9% asymptomatic CE, mirroring large adjuvant trials results. Despite being transient, LVEF drop leads to frequent treatment delays and occasional suspensions. It remains unclear whether LVEF decline is predictive of late CE and at the same time whether treatment efficacy is compromised. A prospective study is needed to assess the optimal way to monitor which will probably implicate in better allocation of resources.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Bruno H R De Paula”
  • BylineArticles whose byline prints “Maria Eduarda Ferro Costa”
  • BylineArticles whose byline prints “Jose Bines”